Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM

AimsFew prior studies have explored the relationship between phenylalanine and diabetic small vessel disease (SVD) in patients with different durations of type 2 diabetes mellitus(T2DM). Our study aimed to explore whether phenylalanine is associated with the risk of SVD and to further explore whethe...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Zheng, Wei Zhang, Yu-Yang Miao, Xue-Rui Li, Wei-Ming Luo, Xi-Lin Yang, Zhong-Ze Fang, Qiang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1472967/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561283963387904
author Jun Zheng
Wei Zhang
Yu-Yang Miao
Xue-Rui Li
Wei-Ming Luo
Xi-Lin Yang
Zhong-Ze Fang
Qiang Zhang
author_facet Jun Zheng
Wei Zhang
Yu-Yang Miao
Xue-Rui Li
Wei-Ming Luo
Xi-Lin Yang
Zhong-Ze Fang
Qiang Zhang
author_sort Jun Zheng
collection DOAJ
description AimsFew prior studies have explored the relationship between phenylalanine and diabetic small vessel disease (SVD) in patients with different durations of type 2 diabetes mellitus(T2DM). Our study aimed to explore whether phenylalanine is associated with the risk of SVD and to further explore whether phenylalanine interacted with the duration of T2DM to alter the risk of SVD.Materials and methodsA total of 1,032 T2DM patients were enrolled using the Liaoning Medical University First Affiliated Hospital (LMUFAH) system. SVD was defined as patients with diabetic nephropathy (DN) or diabetic retinopathy (DR) alone, or both. Serum amino acids were measured by mass spectrometry (MS) technology. A binary logistic regression model was used to examine associations of phenylalanine with SVD risk. Restricted cubic spline (RCS) regression was used to draw the odds ratio curves of plasma phenylalanine for SVD. Additive interaction analysis was employed to test the interaction of low phenylalanine with a long duration of T2DM for SVD.ResultsAmong the 1,032 T2DM patients, 286 (27.7%) had SVD. Phenylalanine <42μmol/L was associated with a markedly increased risk of SVD (OR 1.76, 95%CI 1.23 to 2.51), which was enhanced by a duration of T2DM of ≥5 years to 4.83 (95%CI 2.97-7.87) with significant additive interactions. The inclusion of phenylalanine and duration of T2DM into a traditional risk factor model substantially increased the area under the receiver operating characteristic curve from 0.67 to 0.71 (95% CI 0.70 to 0.75) (P <0.05).ConclusionsIn Chinese patients with T2DM, phenylalanine <42μmol/L was associated with an increased risk of SVD, which was further amplified by a duration of T2DM of ≥5 years.
format Article
id doaj-art-af8306a7a64040eabe873d1219dc14e1
institution Kabale University
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-af8306a7a64040eabe873d1219dc14e12025-01-03T04:11:12ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.14729671472967Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DMJun Zheng0Wei Zhang1Yu-Yang Miao2Xue-Rui Li3Wei-Ming Luo4Xi-Lin Yang5Zhong-Ze Fang6Qiang Zhang7Department of Geriatrics, Tianjin Medical University General Hospital, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in the Central Nervous System, Ministry of Education, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Elderly Health, Tianjin Geriatrics Institute, Tianjin, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, ChinaDepartment of Geriatrics, Tianjin Medical University General Hospital, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in the Central Nervous System, Ministry of Education, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Elderly Health, Tianjin Geriatrics Institute, Tianjin, ChinaDepartment of Geriatrics, Tianjin Medical University General Hospital, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in the Central Nervous System, Ministry of Education, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Elderly Health, Tianjin Geriatrics Institute, Tianjin, ChinaDepartment of Toxicology and Sanitary Chemistry, School of Public Health, Tianjin Medical University, Tianjin, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, ChinaDepartment of Toxicology and Sanitary Chemistry, School of Public Health, Tianjin Medical University, Tianjin, ChinaDepartment of Geriatrics, Tianjin Medical University General Hospital, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in the Central Nervous System, Ministry of Education, State Key Laboratory of Experimental Hematology, Tianjin Key Laboratory of Elderly Health, Tianjin Geriatrics Institute, Tianjin, ChinaAimsFew prior studies have explored the relationship between phenylalanine and diabetic small vessel disease (SVD) in patients with different durations of type 2 diabetes mellitus(T2DM). Our study aimed to explore whether phenylalanine is associated with the risk of SVD and to further explore whether phenylalanine interacted with the duration of T2DM to alter the risk of SVD.Materials and methodsA total of 1,032 T2DM patients were enrolled using the Liaoning Medical University First Affiliated Hospital (LMUFAH) system. SVD was defined as patients with diabetic nephropathy (DN) or diabetic retinopathy (DR) alone, or both. Serum amino acids were measured by mass spectrometry (MS) technology. A binary logistic regression model was used to examine associations of phenylalanine with SVD risk. Restricted cubic spline (RCS) regression was used to draw the odds ratio curves of plasma phenylalanine for SVD. Additive interaction analysis was employed to test the interaction of low phenylalanine with a long duration of T2DM for SVD.ResultsAmong the 1,032 T2DM patients, 286 (27.7%) had SVD. Phenylalanine <42μmol/L was associated with a markedly increased risk of SVD (OR 1.76, 95%CI 1.23 to 2.51), which was enhanced by a duration of T2DM of ≥5 years to 4.83 (95%CI 2.97-7.87) with significant additive interactions. The inclusion of phenylalanine and duration of T2DM into a traditional risk factor model substantially increased the area under the receiver operating characteristic curve from 0.67 to 0.71 (95% CI 0.70 to 0.75) (P <0.05).ConclusionsIn Chinese patients with T2DM, phenylalanine <42μmol/L was associated with an increased risk of SVD, which was further amplified by a duration of T2DM of ≥5 years.https://www.frontiersin.org/articles/10.3389/fendo.2024.1472967/fulltype 2 diabetes mellitussmall vessel diseasephenylalanineduration of diabetesT2DM
spellingShingle Jun Zheng
Wei Zhang
Yu-Yang Miao
Xue-Rui Li
Wei-Ming Luo
Xi-Lin Yang
Zhong-Ze Fang
Qiang Zhang
Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
Frontiers in Endocrinology
type 2 diabetes mellitus
small vessel disease
phenylalanine
duration of diabetes
T2DM
title Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
title_full Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
title_fullStr Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
title_full_unstemmed Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
title_short Interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in Chinese patients with T2DM
title_sort interactive effect of phenylalanine with duration of diabetes on the risk of small vessel disease in chinese patients with t2dm
topic type 2 diabetes mellitus
small vessel disease
phenylalanine
duration of diabetes
T2DM
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1472967/full
work_keys_str_mv AT junzheng interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT weizhang interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT yuyangmiao interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT xueruili interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT weimingluo interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT xilinyang interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT zhongzefang interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm
AT qiangzhang interactiveeffectofphenylalaninewithdurationofdiabetesontheriskofsmallvesseldiseaseinchinesepatientswitht2dm